For the first time, people at high risk of lung cancer can participate in a clinical trial of an experimental vaccine designed to prevent the disease. Led by University College London and the University of Oxford, this groundbreaking trial…
Continue Reading
News Source: timesofindia.indiatimes.com

Leave a Reply